Platform portabel ngaramal efektivitas chemo pikeun penderita kanker individu

Rutgers researchers have created a portable device that they say can determine the efficacy of chemotherapy drugs, for a specific patient, in real time, with an accuracy of almost 96 percent. Teaming biosensors with machine learning, the device provides immediate results, aiding the selection of better drugs while reducing potential side effects.

Artikel ieu mimiti mecenghul di